Verdict87/ 100
Grade B+ · #10Ro
Editorial reviewA heavyweight telehealth brand with brand-name access and a polished experience — but opaque compounded pricing.
Visit RoHead-to-head verdict
Ro vs Vaylen
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, no pay-to-win placement.
vs
Verdict88/ 100
Grade B+ · #5Vaylen
Editorial reviewThe widest formulary on the board — both molecules, brand-name and oral routes — nationwide and LegitScript-verified.
Visit VaylenThe verdict
Winner: Vaylen
Vaylen takes it with a higher Verdict Score — 88/100 to 87/100 (grade B+ vs B+). Anyone who wants every option on one account: compounded, brand-name or oral, without leaving to shop around. Ro still earns its place — patients who want a big, brand-name-capable platform and insurance navigation.
Neither of these is our overall #1. That title goes to CoreAge Rx (94/100) — the most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
89Real-world results86
89
Real-world results86
80Price honesty87
80
Price honesty87
90Prescriber access90
90
Prescriber access90
92Formulary choice91
92
Formulary choice91
86Cancellation fairness86
86
Cancellation fairness86
88Member support86
88
Member support86
Price, coverage & features
| Metric | Ro | Vaylen |
|---|---|---|
| Verdict Score | 87/100 | 88/100 |
| Grade | B+ | B+ |
| Semaglutide | Not disclosed | $179/mo |
| Tirzepatide | Not disclosed | $239/mo |
| Coverage | Multi-state | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
| Relationship | Editorial | Editorial |
Ro
What we like
- Brand-name (Wegovy/Zepbound) access and insurance support
- Oral options
- Polished, well-funded platform
The caveats
- Does not publicly disclose compounded pricing up front
- Premium positioning
Vaylen
What we like
- Full formulary: both molecules plus brand-name and oral routes
- LegitScript-certified and available in all 50 states
- Fair mid-market pricing for the breadth on offer
The caveats
- Not the cheapest per molecule
- Younger brand without a long outcomes record
Also worth a look
Patients who want a big, brand-name-capable platform and insurance navigation.
Visit Ro Read the full Ro review →Our pick — visit
Anyone who wants every option on one account: compounded, brand-name or oral, without leaving to shop around.
Visit Vaylen Read the full Vaylen review →Keep comparing
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.